What does success actually mean?
Define the primary operating, clinical, quality, financial, or decision outcome; secondary outcomes; guardrails; and the threshold that would justify expansion.
AI pilot evaluation and scale-readiness for healthcare, health plans, and other regulated enterprises that already have a pilot or early deployment — but still need a defensible answer to whether it works in the real workflow, creates enough value, and is ready for broader use.
Technical performance is not the same as real-world efficacy. A scale decision needs evidence that the AI improved the outcome that matters in the actual workflow, under conditions leadership understands, at economics the organization can support.
The engagement is built around the decision leadership needs to make, not around producing an evaluation report for its own sake.
Define the primary operating, clinical, quality, financial, or decision outcome; secondary outcomes; guardrails; and the threshold that would justify expansion.
Review the cohort, baseline or comparator, exposure, sample support, observation window, confounders, instrumentation, and missing outcome data.
Measure adoption, task completion, human intervention, exceptions, delays, failure modes, downstream effects, and whether model performance translated into operating performance.
Look beyond the average result to identify users, cases, contexts, and operating conditions where benefit, burden, or failure meaningfully changes.
Estimate operating value against retained human handling, rework, delay, AI/control cost, and implementation effort using the evidence the pilot actually produced.
Recommend whether to scale, narrow the use case, redesign the pilot, extend measurement, collect specific missing evidence, change the workflow, or stop.
The exact design depends on the pilot, available data, operational constraints, and whether prospective evaluation is still possible.
Define the scale/no-scale question, stakeholders, claimed value, consequence of being wrong, and evidence already available.
Review endpoints, comparator, cohort, instrumentation, workflow exposure, confounding, adoption measurement, and economics.
Use the strongest feasible design for the environment, which may include prospective measurement, quasi-experimental comparison, stratified analysis, or a redesigned pilot.
Return the evidence, remaining uncertainty, conditions for expansion, and the specific next move.
Scope is one AI pilot or early deployment. Timing and commercial terms depend on evidence already available, data access, and the depth of analysis required.
Commercial terms confirmed on the fit call. No forced fit. The right conclusion can be scale, narrow, redesign, extend measurement, move into Decision Control Assessment, or stop.
A pilot can prove useful and still require decision-level control before broader operational authority is appropriate. If the unresolved question becomes how much authority AI should have in production, when verification or human review is required, or where persistent control is needed after launch, the next step may be a Decision Control Assessment.
Bring the current evaluation plan, available results, and the business decision leadership needs to make. We will determine whether this engagement is the right fit.